Related Experiment Videos
A(1,2)BO(1,2) genotyping by multiplexed allele-specific PCR
1Clinical Laboratories, The Blood Center of Southeastern Wisconsin, Milwaukee 53233, USA.
British Journal of Haematology
|February 5, 1998
Summary
A new allele-specific PCR genotyping assay accurately determines ABO blood group subtypes (A1, A2, B, O1, O2). This molecular method offers a rapid and reliable alternative to traditional serological typing for transfusion medicine.
Area of Science:
- Immunogenetics
- Molecular Biology
- Transfusion Medicine
Background:
- The ABO blood group system is crucial in transfusion medicine, involving A, B, and H antigens.
- While ABO immunology is well-understood, its genetic basis has only recently been elucidated.
- This genetic understanding facilitates the development of molecular typing methods.
Purpose of the Study:
- To develop and validate a multiplex allele-specific PCR (ASPCR) genotyping assay for A1, A2, B, O1, and O2 blood group subtypes.
- To assess the accuracy and efficiency of the developed ASPCR assay compared to traditional serological methods.
Main Methods:
- A two-reaction multiplex allele-specific PCR (ASPCR) assay was designed.
- Eleven allele-specific oligonucleotide primers were used to detect specific genetic variations associated with ABO subtypes.
- The assay was tested on 122 peripheral blood samples, with results compared to serological typing.
Main Results:
- The ASPCR assay successfully genotyped A1, A2, B, O1, and O2 subtypes.
- A high concordance rate of 98.4% (120/122 samples) was achieved between the molecular genotyping and serological typing.
- The assay demonstrated accuracy, speed, and simplicity in ABO genotyping.
Conclusions:
- The developed ASPCR assay is a rapid, accurate, and simple method for A(1,2)BO(1,2) genotyping.
- This molecular assay serves as a valuable supplement to standard serological ABO typing in clinical settings.